Inclusion Criteria:  AHDS with characteristic clinical phenotype and with genetically confirmed mutation in the MCT8 gene SLC16A2.  Exclusion Criteria:  Inability to get the study medication glycerol phenylbutyrate per-os (in cases without gastrotstomy) Known contra-indication for glycerol phenylbutyrate Patients without confirmed mutation in the MCT8 gene